Mechanistic Actions of microRNAs in Diabetic Wound Healing

Marija Petkovic1,2,3, Anja Elaine Sørensen1, Ermelindo Carreira Leal2,3

  • 1Department of Science and Environment, Roskilde University, 4000 Roskilde, Denmark.

Cells
|October 7, 2020
PubMed

Insights

Diabetes impairs wound healing, leading to costly chronic wounds. MicroRNAs (miRNAs) are key regulators in this process and show promise as diagnostic biomarkers and therapeutic targets for improved diabetes wound care.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Endocrinology

Background:

  • Wound healing is a complex biological process significantly impaired in diabetic patients.
  • Chronic non-healing diabetic wounds represent a major global healthcare cost.
  • Current diagnostic and treatment strategies for these wounds are insufficient.

Purpose of the Study:

  • To review the mechanistic role of microRNAs (miRNAs) in impaired wound healing.
  • To discuss the potential of miRNAs as biomarkers for chronic wounds.
  • To explore miRNAs as therapeutic targets for non-healing diabetic wounds.

Main Methods:

  • Literature review and synthesis of existing research on miRNAs in wound healing.
  • Analysis of the regulatory functions of miRNAs in gene and protein expression.
  • Discussion of the implications of miRNA dysregulation in diabetes-associated wound complications.

Main Results:

  • MicroRNAs (miRNAs) are critical regulatory molecules involved in gene expression.
  • miRNAs play significant roles in the pathophysiology of impaired wound healing in diabetes.
  • Dysregulated miRNA expression contributes to chronic non-healing wounds.

Conclusions:

  • MicroRNAs (miRNAs) are emerging as crucial factors in the impaired wound healing observed in diabetes.
  • miRNAs hold potential as specific biomarkers for early diagnosis of chronic wounds.
  • Targeting miRNAs may offer novel therapeutic strategies for treating non-healing diabetic wounds.